Cetera Investment Advisers’s Ascendis Pharma A/S ASND Stock Holding History

Cetera Investment Advisers’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Buy	6,283 +1,296	+26%	+$303K	﹤0.01%	2544
2026 Q1	$1.14M	Buy	4,987 +439	+10%	+$98.4K	﹤0.01%	2795
2025 Q4	$970K	Buy	4,548 +723	+19%	+$149K	﹤0.01%	2848
2025 Q3	$760K	Buy	3,825 +625	+20%	+$117K	﹤0.01%	3029
2025 Q2	$552K	Buy	+3,200	New	+$521K	﹤0.01%	2889

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cetera Investment Advisers's ASND Position: Q2 2026 in Review

Cetera Investment Advisers increased its Ascendis Pharma A/S (ASND) stake by 26% in Q2 2026, buying an estimated $303K and bringing the position to 6,283 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

Cetera Investment Advisers first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Cetera Investment Advisers held 6,283 shares of Ascendis Pharma A/S worth $1.68M as of Q2 2026.
Cetera Investment Advisers bought 1,296 Ascendis Pharma A/S shares in Q2 2026, an estimated $303K.
Ascendis Pharma A/S made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2544 holding.
Cetera Investment Advisers first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.